Journal of Cancer Biomoleculars and Therapeutics is a peer-reviewed english-language open-access journal published by ETERNO PRESS SDN. BHD. in Malaysia, operating under an open-access model since 2024. The journal covers Internal medicine.
Authors are required to pay an article processing charge to publish in Journal of Cancer Biomoleculars and Therapeutics; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY license (see other journals using this license).
To date, Journal of Cancer Biomoleculars and Therapeutics has published 44 articles. Articles are minted with DOIs through the prefix 10.62382. All submissions undergo plagiarism screening before peer review.
Keywords
cancer, biomolecules, therapeutics, molecular targeted therapy, precision oncology, cancer therapy
At a glance
- Publisher
- ETERNO PRESS SDN. BHD.
- Country
- Malaysia
- Primary language
- English
- License
- CC BY
- Peer review
- Double anonymous peer review
- OA since
- 2024
- Review time
- 13 weeks
- DOI prefix
10.62382- Plagiarism check
- Yes
ISSN
- electronic
- 3060-8856
Frequently asked questions
Is Journal of Cancer Biomoleculars and Therapeutics peer-reviewed?
Does Journal of Cancer Biomoleculars and Therapeutics charge an article processing charge (APC)?
What subjects does Journal of Cancer Biomoleculars and Therapeutics publish?
What languages does Journal of Cancer Biomoleculars and Therapeutics accept?
What is the ISSN of Journal of Cancer Biomoleculars and Therapeutics?
3060-8856 (electronic).